BPA for inbrija and ampyra
Ended Awarded Last action
- Contract number
- 36E79724A0005
- Awardee
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $5,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The provided information describes a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders.
The single-award BPA (Contract #36E79724A0005) has a ceiling value of $5,500,000 and is effective from January 18, 2024 to September 19, 2024. It was awarded without the use of a set-aside and enables the VA to procure Acorda's pharmaceutical products Inbrija and Ampyra, which are used to manage the symptoms of Parkinson's disease and multiple sclerosis, respectively. Acorda Therapeutics has a history of supplying drugs and pharmaceuticals to various federal agencies, particularly the VA, and holds several significant federal contract Indefinite Delivery Vehicles (IDVs), including a Federal Supply Schedule contract and another BPA for Inbrija and Ampyra. These IDVs facilitate the streamlined procurement of Acorda's neurological medications by VA medical facilities and pharmacies nationwide, supporting the agency's mission to provide quality healthcare to veterans.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0005?
36E79724A0005 was awarded to Acorda Therapeutics, Inc. by National Acquisition Center (Headquarters) on January 18, 2024.
How much is contract 36E79724A0005 worth?
36E79724A0005's own ceiling is $5,500,000.
Who can order from contract 36E79724A0005?
36E79724A0005 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0005 under another contract?
Yes. 36E79724A0005 is a blanket purchase agreement under 36F79723D0194, a federal supply schedule.
Was contract 36E79724A0005 competed?
The extent of competition for 36E79724A0005 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV